| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $34K | — |
| R&D Expense | $408K | +412.7% |
| SG&A Expense | $50.0M | +1920.7% |
| Operating Income | -$54.4M | -1549.1% |
| Interest Expense | $726K | +403.6% |
| Pre-tax Income | -$86.3M | -2306.4% |
| Net Income | -$86.3M | -2310.2% |
| EPS (Basic) | -$0.16 | -1500.0% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $14K | — |
| Inventory | $69K | — |
| Current Assets | $4.8M | +495.4% |
| Total Assets | $37.9M | +149.1% |
| Current Liabilities | $21.8M | +393.6% |
| Total Liabilities | $24.9M | +145.8% |
| Stockholders' Equity | -$33.1M | +38.3% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.6M | -429.0% |
| Investing Cash Flow | -$8.4M | -11.9% |
| Financing Cash Flow | $22.6M | +126.7% |